Assignee
CREAGENE INC
KR·4 granted patents·5 pending applications·44 citations·filing 1998–2009
Top patents by PatentIndex Score
9 records- 0186US7101844B2Cytoplasmic transduction peptides and uses thereofCREAGENE INC·Filed 2003·Granted Sep 5, 2006·26 cites·7 claims
- 0271US7138274B2Advanced oral poliovirus vaccine (Adv-OPV) deprived of the possibility of vaccine associated paralytic poliomyelities (VAPP)CREAGENE INC·Filed 2004·Granted Nov 21, 2006·4 cites·15 claims
- 0369US6780618B2Method for improving genetic stability of foreign insert nucleotide sequence in recombinant poliovirusCREAGENE INC·Filed 2002·Granted Aug 24, 2004·2 cites·45 claims
- 0446US2009293138A1Animal models carrying tumors expressing human prostate cancer-specific antigen and method for analyzing prevention and treatment efficacy of dendritic cells-derived immunotherapeuticsCREAGENE INC·Filed 2006·Application pending·0 cites
- 0544US2010055076A1Mesenchymal stem cell-mediated autologous dendritic cells with increased immunosuppressionCREAGENE INC·Filed 2009·Application pending·0 cites
- 0641US6696289B1Replication-competent recombinant Sabin type 1 strain of poliovirusCREAGENE INC·Filed 1998·Granted Feb 24, 2004·12 cites·13 claims
- 0741US2010215624A1Pharmaceutical Compositions for Treating Rheumatoid Arthritis Comprising Semi-Mature Dendritic CellCREAGENE INC·Filed 2008·Application pending·0 cites
- 0841US2010235932A1Animal models carrying tumors expressing human liver cancer-specific antigen and method for analyzing prevention and treatment efficacy of dendritic cells-derived immunotherapeutics using the aboveCREAGENE INC·Filed 2008·Application pending·0 cites
- 0940US2009029387A1Method for effectively measuring the activity of cytotoxic t lymphocytes in human and out-bred animalsCREAGENE INC·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CREAGENE INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →